CSIMarket
 
Plum Acquisition Corp I  (NASDAQ: PLMIU)
Other Ticker:  
 
 
Price: $10.8900 $1.19 12.268%
Day's High: $11.29 Week Perf: -12.81 %
Day's Low: $ 9.90 30 Day Perf: 2.45 %
Volume (M): 2 52 Wk High: $ 18.00
Volume (M$): $ 26 52 Wk Avg: $10.84
Open: $9.90 52 Wk Low: $8.30



 Market Capitalization (Millions $) 243
 Shares Outstanding (Millions) 22
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -39
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0

Plum Acquisition Corp I
Plum Acquisition Corp I is a Special Purpose Acquisition Company (SPAC) formed for the purpose of merging with or acquiring a private company. The company went public through an initial public offering (IPO) and raised funds to identify and complete a transaction in the healthcare industry. Plum Acquisition Corp I focuses on industries related to pharmaceuticals, biotechnology, life sciences, medical devices, healthcare services, and digital health. They aim to find a target company that can benefit from their expertise and industry relationships to create value for their shareholders.


   Company Address: 2021 Fillmore St. #2089 San Francisco 94115 CA
   Company Phone Number: 683-6773   Stock Exchange / Ticker: NASDAQ PLMIU


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
APTM        0.66% 
• View Complete Report
   



Plum Acquisition Corp I

Plum Acquisition Corp I Revs Up Strategies to Reignite Revenue Growth in Fiscal Year 2023



This article delves into the fiscal interval ending September 30, 2023, to analyze the financial performance of a company, referred to as PLMIU. Additionally, it examines Plum Acquisition Corp I's net deficit during the same reporting period. By exploring key metrics such as earnings per share, revenue, and net earnings, we aim to gain insights into the company's financial situation and potential underlying factors.
Deficit in Earnings per Share:
In the fiscal interval ending September 30, 2023, PLMIU experienced a significant decrease in earnings per share. It slipped into a deficit of $-0.36 per share compared to $0.06 recorded in the corresponding period the previous year. This decline indicates an unfavorable financial outcome, potentially attributed to various factors impacting the company's profitability during this reporting period.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com